Preliminary H1 2026 revenue of approximately $11 million, increased 120% vs. H1 2025, underscoring strong operating momentum. Supported by approximately $495 million in cash and short-term investments ...

For millions of people living with depression, finding an effective treatment can feel like a long and uncertain journey.

Genomic surveillance—the process of monitoring and sequencing pathogens—is one of the most important tools for detecting ...

By 2050, scientists estimate that antibiotic-resistant infections will be associated with more than 8 million deaths around ...